With recent court rulings in the US against Prometheus Laboratories and Myriad Genetics, rules issued by the Patent and Trademark Office say that for an invention to be patentable it has to be "significantly different" from natural products.
Registering provides access to this and other free content.
Already have an account?Login Now.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.